MNPR - Monopar Therapeutics GAAP EPS of -$2.23
2025-03-31 13:05:16 ET
More on Monopar Therapeutics
- Monopar Therapeutics: Strong Data, But There Are Risks
- Monopar a new overweight at Piper Sandler on rare disease asset
- Seeking Alpha’s Quant Rating on Monopar Therapeutics
- Historical earnings data for Monopar Therapeutics
- Financial information for Monopar Therapeutics